Skip to main content
Erschienen in: Archives of Dermatological Research 9/2023

22.08.2023 | STUDY PROTOCOL

The effect of vitamin C on oxidative stress indices and skin regimentation of vitiligo patients

verfasst von: Maryam Fallah, Robabeh Abedini, Somayyeh Asghari Mahiabadi, Sahar Montazeri, Mohammad Javad Hosseinzadeh-Attar, Soraiya Ebrahimpour-Koujan

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

It has been suggested that vitamin C is involved in suppressing stress oxidation signaling in vitiligo disease. However, the effect of vitamin C supplementation on stress oxidative factors has not been investigated in vitiligo subjects. This study was designed to examine the effects on vitamin C supplementation on serum levels of stress oxidative factors and regimentation in vitiligo patients. Forty-four vitiligo patients will be recruited in this study. After block matching for sex and number of phototherapy sessions, they will be randomly assigned to receive 1000 mg/d vitamin C or placebo for 8 weeks. The weight, height, and waist circumference of participants will be measured. Determination of serum stress oxidative indices (CAT, SOD, GPX, MDA, TOS, TAC) will be done at study baseline and at the end of the trial. Also, the regimentation will be determined using the VASI score. This is the first randomized controlled trial that will determine the effect of vitamin C supplementation on serum levels of stress oxidative indices and regimentation in vitiligo patients. The results of this trial will provide clinical evidence on the effectiveness of vitamin C supplementation in controlling oxidative stress in vitiligo patients. Trial registration number: This study is registered in the Iranian Registry of Clinical Trials website (available at http://​www.​irct.​ir, identifier: IRCT20230123057193N1), Registration date: 2023/04/17.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F (2020) Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health Qual Life Outcomes 18(1):1–7CrossRef Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F (2020) Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health Qual Life Outcomes 18(1):1–7CrossRef
3.
Zurück zum Zitat Silverberg NB (2015) The epidemiology of vitiligo. Curr Dermatol Rep 4(1):36–43CrossRef Silverberg NB (2015) The epidemiology of vitiligo. Curr Dermatol Rep 4(1):36–43CrossRef
4.
Zurück zum Zitat Afkhami-Ardekani M, Ghadiri-Anari A, Ebrahimzadeh-Ardakani M, Zaji N (2014) Prevalence of vitiligo among type 2 diabetic patients in an Iranian population. Int J Dermatol 53(8):956–958CrossRefPubMed Afkhami-Ardekani M, Ghadiri-Anari A, Ebrahimzadeh-Ardakani M, Zaji N (2014) Prevalence of vitiligo among type 2 diabetic patients in an Iranian population. Int J Dermatol 53(8):956–958CrossRefPubMed
5.
Zurück zum Zitat Majid I (2010) Vitiligo management: an update. Br J Med Pract 3(3) Majid I (2010) Vitiligo management: an update. Br J Med Pract 3(3)
6.
Zurück zum Zitat Montes LF, Wilborn WH, Hyde BM, Vaughan JT, Bennett JS (2008) Vitiligo in a quarter horse filly: clinicopathologic, ultrastructural, and nutritional study. J Equine Vet 28(3):171–175CrossRef Montes LF, Wilborn WH, Hyde BM, Vaughan JT, Bennett JS (2008) Vitiligo in a quarter horse filly: clinicopathologic, ultrastructural, and nutritional study. J Equine Vet 28(3):171–175CrossRef
7.
Zurück zum Zitat Shaker O, El-Tahlawi S (2008) Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol 159(3):720–724PubMed Shaker O, El-Tahlawi S (2008) Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol 159(3):720–724PubMed
8.
Zurück zum Zitat Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M (2008) Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian J Dermatol 53(3):106CrossRefPubMedPubMedCentral Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M (2008) Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian J Dermatol 53(3):106CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Huo J, Liu T, Huan Y, Li F, Wang R (2020) Serum level of antioxidant vitamins and minerals in patients with vitiligo, a systematic review and meta-analysis. J Trace Elem Med Biol 62:126570CrossRefPubMed Huo J, Liu T, Huan Y, Li F, Wang R (2020) Serum level of antioxidant vitamins and minerals in patients with vitiligo, a systematic review and meta-analysis. J Trace Elem Med Biol 62:126570CrossRefPubMed
11.
Zurück zum Zitat Weidinger A, Kozlov AV (2015) Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomolecules 5(2):472–484CrossRefPubMedPubMedCentral Weidinger A, Kozlov AV (2015) Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomolecules 5(2):472–484CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Dell’Anna M, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin A et al (2007) Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exper Dermatol 32(6):631–636CrossRef Dell’Anna M, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin A et al (2007) Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exper Dermatol 32(6):631–636CrossRef
13.
Zurück zum Zitat Choi H-I, Park J-I, Kim H-J, Kim D-W, Kim S-S (2009) A novel L-ascorbic acid and peptide conjugate with increased stability and collagen biosynthesis. BMB Rep 42(11):743–746CrossRefPubMed Choi H-I, Park J-I, Kim H-J, Kim D-W, Kim S-S (2009) A novel L-ascorbic acid and peptide conjugate with increased stability and collagen biosynthesis. BMB Rep 42(11):743–746CrossRefPubMed
14.
Zurück zum Zitat Zheleva A, Nikolova G, Karamalakova Y, Hristakieva E, Lavcheva R, Gadjeva V (2018) Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy. Regul Toxicol Pharmacol 94:234–239CrossRefPubMed Zheleva A, Nikolova G, Karamalakova Y, Hristakieva E, Lavcheva R, Gadjeva V (2018) Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy. Regul Toxicol Pharmacol 94:234–239CrossRefPubMed
15.
Zurück zum Zitat Sendrasoa FA, Ranaivo IM, Sata M, Andrianarison M, Raharolahy O, Rakotoarisaona MF et al (2019) Treatment responses in patients with Vitiligo to very potent topical corticosteroids combined with vitaminotherapy in Madagascar. Int J Dermatol 58(8):908–911CrossRefPubMed Sendrasoa FA, Ranaivo IM, Sata M, Andrianarison M, Raharolahy O, Rakotoarisaona MF et al (2019) Treatment responses in patients with Vitiligo to very potent topical corticosteroids combined with vitaminotherapy in Madagascar. Int J Dermatol 58(8):908–911CrossRefPubMed
16.
Zurück zum Zitat Don P, Iuga A, Dacko A, Hardick K (2006) Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol 45(1):63–65CrossRefPubMed Don P, Iuga A, Dacko A, Hardick K (2006) Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol 45(1):63–65CrossRefPubMed
17.
Zurück zum Zitat Dell’Anna M, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin A et al (2007) Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 32(6):631–636CrossRefPubMed Dell’Anna M, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin A et al (2007) Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 32(6):631–636CrossRefPubMed
18.
Zurück zum Zitat Kang M, Ragan BG, Park J-H (2008) Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train 43(2):215–221CrossRefPubMedPubMedCentral Kang M, Ragan BG, Park J-H (2008) Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train 43(2):215–221CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Saghaei M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4(1):1–6CrossRef Saghaei M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4(1):1–6CrossRef
21.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9;SUPP/1):S498–S504CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9;SUPP/1):S498–S504CrossRefPubMed
22.
Zurück zum Zitat Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 140(6):677–683CrossRefPubMed Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 140(6):677–683CrossRefPubMed
23.
Zurück zum Zitat Komen L, van der Kraaij G, van der Veen J, de Rie M, Wolkerstorfer A (2015) The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo. J Eur Acad Dermatol Venereol 29(11):2145–2151CrossRefPubMed Komen L, van der Kraaij G, van der Veen J, de Rie M, Wolkerstorfer A (2015) The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo. J Eur Acad Dermatol Venereol 29(11):2145–2151CrossRefPubMed
24.
Zurück zum Zitat Kitchen H, Wyrwich KW, Carmichael C, Deal LS, Lukic T, Al-Zubeidi T et al (2022) Meaningful changes in what matters to individuals with vitiligo: content validity and meaningful change thresholds of the vitiligo area scoring index (VASI). Dermatol Therapy 12(7):1623–1637CrossRef Kitchen H, Wyrwich KW, Carmichael C, Deal LS, Lukic T, Al-Zubeidi T et al (2022) Meaningful changes in what matters to individuals with vitiligo: content validity and meaningful change thresholds of the vitiligo area scoring index (VASI). Dermatol Therapy 12(7):1623–1637CrossRef
27.
28.
Metadaten
Titel
The effect of vitamin C on oxidative stress indices and skin regimentation of vitiligo patients
verfasst von
Maryam Fallah
Robabeh Abedini
Somayyeh Asghari Mahiabadi
Sahar Montazeri
Mohammad Javad Hosseinzadeh-Attar
Soraiya Ebrahimpour-Koujan
Publikationsdatum
22.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02687-2

Weitere Artikel der Ausgabe 9/2023

Archives of Dermatological Research 9/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.